| ID | 2849 |
| No | 2849 |
| Brand Name | KEFUCLAV 250 |
| Ingredients | CEFUROXIME AXETIL USP 312.5 MG EQ.TO CEFUROXIME 250 MG, DILUTED POTASSIUM CLAVULANATE( WITH AVICEL) BP 148.81 MG EQ.TO CLAVULANIC ACID 62.5 MG |
| Dosage Form | FILM-COATED TABLETS |
| Primary Packaging | ALU-ALU STRIP |
| Storage | |
| Shelf Life | 2 YEARS |
| Pack Size | BOX OF 2 X 7'S |
| Dispensing Category | |
| ATC Classification | |
| Pharmaceutical Class | |
| Indications | PHARYNGITIS/TONSILLITIS, ACUTE BACTERIAL OTITIS MEDIA, ACUTE BACTERIAL MAXILLARY SINUSITIS, ACUTE BACTERIAL EXACERBATIONS OF CHRONIC BRONCHITIS AND SECONDARY BACTERIAL INFECTIONS OF ACUTE BRONCHITIS, UNCOMPLICATED SKIN AND SKIN-STRUCTURE INFECTIONS, UNCOMPLICATED URINARY TRACT INFECTION, UNCOMPLICATED GONORRHEA. |
| Contraindications | |
| Side Effects | |
| Unit Price | |
| EDL | NULL |
| Description | LIGHT YELLOW TO YELLOW CAPLET SHAPE, DEEP BICONVEX FILM COATED TABLET, ONE SCORE ON ONE SIDE |
| Note | |
| License Owner | VIMPEX (LAO) CO.,LTD |
| Manufacturer | ESKAYEF PHARMACEUTICALS LIMITED |
| Country | BANGLADESH |
| Import Registration No | |
| Import Registration Date | |
| Activity | CERTIFICATE RELEASED |
| Applied Date | |
| FDD Registration No | 07 I 4523/18 |
| FDD Registration Date | 07/07/2025 |
| Expiry Date | 06/07/2030 |